Allena Pharmaceuticals

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena Pharmaceuticals went public in November 2017 (NASDAQ: ALNA).

NASDAQ: ALNA

Investors

Steve Kraus

Founded

2011

Partnered

2011

Roadmaps